HUP0102389A2 - IBD vírustörzs in ovo adagoláshoz - Google Patents

IBD vírustörzs in ovo adagoláshoz

Info

Publication number
HUP0102389A2
HUP0102389A2 HU0102389A HUP0102389A HUP0102389A2 HU P0102389 A2 HUP0102389 A2 HU P0102389A2 HU 0102389 A HU0102389 A HU 0102389A HU P0102389 A HUP0102389 A HU P0102389A HU P0102389 A2 HUP0102389 A2 HU P0102389A2
Authority
HU
Hungary
Prior art keywords
virus
vaccine
strain
ibdv
diluent
Prior art date
Application number
HU0102389A
Other languages
English (en)
Inventor
E. Egbert Mundt
Adriaan Antonius Wilhelmus Maria Van Loon
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HU0102389D0 publication Critical patent/HU0102389D0/hu
Publication of HUP0102389A2 publication Critical patent/HUP0102389A2/hu
Publication of HUP0102389A3 publication Critical patent/HUP0102389A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A tal lm ny egy Gumborói betegség vírus (infectious bursal diseasevírus IBDV) t"rzsre, egy Gumborói betegség (IBD) elleni vakcin ra, avírus kitenyésztésének elj r s ra, vakcinaelő llít si elj r sra,valamint a vírusnak a vakcinaelő llít si elj r sban való alkalmaz s ravonatkozik. A tal lm ny szerinti vírus t"rzs a Gumborói betegségvírust"rzse, amelynek mint ja az European Collection of Cell Cultures(Salisbury, Viltshine, SP4 OJG, Nagy-Britannia) t"rzsgyűjteményben vanletétbe helyezve V00012609 sz mon. A tal lm ny szerinti vírus t"rzsetoly módon llítj k elő, hogy a vírust egy megfelelő szubsztr tontenyésztik, és elkül"nítik a szubsztr ttól, az említett műveleteketismert módon végezve. A tal lm ny szerinti vakcina egy előbbiekszerinti vírust és egy gyógy szati szempontból elfogadható vivőanyagotvagy hígítóanyagot tartalmaz. A vakcin t a vírus és egy gyógy szati szempontból elfogadhatóvivőanyag vagy hígítóanyag "sszekeverésével llítj k elő. Ó
HU0102389A 2000-06-09 2001-06-08 Ibdv straln for in ovo administration HUP0102389A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202042 2000-06-09

Publications (3)

Publication Number Publication Date
HU0102389D0 HU0102389D0 (en) 2001-08-28
HUP0102389A2 true HUP0102389A2 (hu) 2002-04-29
HUP0102389A3 HUP0102389A3 (en) 2005-06-28

Family

ID=8171620

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102389A HUP0102389A3 (en) 2000-06-09 2001-06-08 Ibdv straln for in ovo administration

Country Status (9)

Country Link
US (2) US6451321B1 (hu)
JP (1) JP2002045175A (hu)
KR (1) KR20020013378A (hu)
AU (1) AU782013B2 (hu)
BR (1) BR0102322A (hu)
CA (1) CA2349960A1 (hu)
HU (1) HUP0102389A3 (hu)
MX (1) MXPA01005808A (hu)
ZA (1) ZA200104596B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
US20020104094A1 (en) * 2000-12-01 2002-08-01 Bruce Alexander System and method for processing video data utilizing motion detection and subdivided video fields
MXPA06005424A (es) 2003-11-13 2007-01-25 Univ Georgia Res Found Metodos para caracterizar virus de enfermedad bursal infecciosa.
CA2562136C (en) * 2004-03-31 2012-10-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Novel infectious bursal disease virus and vaccine containing said virus
US7491399B2 (en) * 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
JPWO2007072916A1 (ja) * 2005-12-22 2009-06-04 財団法人化学及血清療法研究所 卵内接種用ワクチン
RU2409385C2 (ru) * 2006-03-30 2011-01-20 Эмбрекс, Инк. Способ иммунизации птицы против инфекции, вызванной бактериями clostridium
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
DE69030383T2 (de) * 1989-10-02 1997-10-23 Univ Arkansas Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
EP0861665A1 (en) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.

Also Published As

Publication number Publication date
US20030068334A1 (en) 2003-04-10
HU0102389D0 (en) 2001-08-28
ZA200104596B (en) 2001-12-06
US6451321B1 (en) 2002-09-17
AU5179101A (en) 2002-01-03
MXPA01005808A (es) 2004-11-10
BR0102322A (pt) 2002-02-13
JP2002045175A (ja) 2002-02-12
KR20020013378A (ko) 2002-02-20
AU782013B2 (en) 2005-06-30
HUP0102389A3 (en) 2005-06-28
CA2349960A1 (en) 2001-12-09

Similar Documents

Publication Publication Date Title
Vogt Phenotypic mixing in the avian tumor virus group
HUP0102389A2 (hu) IBD vírustörzs in ovo adagoláshoz
Hsiung et al. Comparative susceptibility of kidney cells from different monkey species to enteric viruses (poliomyelitis, Coxsackie, and ECHO groups)
WO2003023021A3 (de) Verfahren zur herstellung eines aktiven bestandteils eines arznei- oder diagnosemittels in mdck-zell-suspensionskultur
BR0001011B1 (pt) processo para a preparação de um mutante ibdv infeccioso, mutante ibdv infeccioso engenheirado geneticamente, e, vacina.
CY2051B1 (en) Hiv-3 retrovirus and its use
Kolakofsky et al. Antigenomes in Sendai virions and Sendai virus-infected cells
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
UA82466C2 (uk) Спосіб посилення ампліфікації хордопоксвірусу
IE802485L (en) Infectious-bronchitis vaccines
Madeley Origins of electron microscopy and viral diagnosis.
Poland et al. Host growth and survivorship varies with endosymbiotic algal partner in developing cnidarians
RU2368392C2 (ru) Применение аттенуированного ротавирусного штамма серотипа g1 в изготовлении композиции для индукции иммунного ответа на ротавирусную инфекцию
Tian et al. Molecular taxonomy of five species of microfungi on Alnus spp. from Italy
US4620978A (en) Hepatitis A virus purified and triply cloned
CA2181862A1 (en) Mild newcastle disease virus vaccine
CA1339963C (en) Live combination vaccine containing infectious bronchitis virus
Rowe et al. Quasispecies development by high frequency RNA recombination during MHV persistence
TAKASE et al. Susceptibility of chicken embryos to highly virulent infectious bursal disease virus
EP1161953A3 (en) IBDV strain for in OVO administration
Charleson et al. Lymphoproliferative responses to human papillomaviruses in patients with cutaneous warts
EP0261168A1 (en) Feline infectious peritonitis vaccine
NO965337L (no) Ny nematofag mot rundormer av slekt Meloidogyn
Procopiak et al. Valve morphology of the benthic diatom Fallacia marnieri (Manguin) Witkowski (Sellaphoraceae-Bacillariophyta)
HUP0102823A2 (hu) Széles spektrumú vakcina fertőző, burzális betegség vírusa (IBDV) ellen

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished